iPhone Apps

Before implanting a pacemaker or defibrillator, the practice of temporarily discontinuing the use of the blood thinner warfarin and “bridging” with another anticoagulant, heparin, has been the Gold Standard for a long time — even though doing so may put patients at risk for a stroke. Now, though, “Bruise Control” research done at the University of Ottawa Heart Institute in Canada has shown that operating without interrupting warfarin is safe and actually reduces the risk of bleeding….

Read more here:
Warfarin Safe Before Cardiac Surgery

Before implanting a pacemaker or defibrillator, the practice of temporarily discontinuing the use of the blood thinner warfarin and “bridging” with another anticoagulant, heparin, has been the Gold Standard for a long time — even though doing so may put patients at risk for a stroke. Now, though, “Bruise Control” research done at the University of Ottawa Heart Institute in Canada has shown that operating without interrupting warfarin is safe and actually reduces the risk of bleeding….

See the rest here:
Warfarin Safe Before Cardiac Surgery

Kidney chains let people donate even though organs can’t go to loved ones

Go here to read the rest:
More U.S. Kidney Exchanges Would Allow 1,000 Additional Transplants Yearly

Many popular films use death as plot device even though survival is much improved, researcher says

See the original post:
Cancer Portrayed Too Grimly in Movies, Study Suggests

A possible Alzheimer's disease treatment from drugmaker Eli Lilly showed some promise in late-stage research, even though the drug failed to slow a form of mental decline in two separate studies of patients with the mind-robbing condition. Shares of the Lilly soared Friday in morning trading after the Indianapolis company announced what could be a step toward a long-awaited breakthrough in the fight against a disease that has no cure and ultimately proves fatal

Read the original:
Alzheimer’s Drug Trial Yields Promising Sign